Carna Biosciences
4572.TTSE GROWTHPharmaceutical
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Cantor Fitzgerald Europe | 25.99% |
| Gomi Daisuke | 13.68% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 3
| Athos Capital Limited | 4.87% |
| Morgan Stanley & Co. International plc | 3.33% |
| Morgan Stanley & Co. LLC | 0.00% |
Ownership history · 12
| Holder | Ratio | Change |
|---|---|---|
| Cantor Fitzgerald Europe2026-07-29 | 28.34% | -1.87pp |
| Cantor Fitzgerald Europe2026-06-02 | 30.21% | -1.29pp |
| Cantor Fitzgerald Europe2026-05-20 | 31.50% | -1.70pp |
| Cantor Fitzgerald Europe2026-05-11 · amended | 33.20% | -1.70pp |
| Athos Capital Limited2026-04-16 · amended | 4.87% | -2.46pp |
| Cantor Fitzgerald Europe2026-02-20 · amended | 34.90% | +19.88pp |
| Gomi Daisuke2026-01-13 | 5.14% | new |
| Cantor Fitzgerald Europe2025-11-28 | 15.02% | +5.34pp |
| Cantor Fitzgerald Europe2025-10-03 · amended | 9.68% | new |
| Athos Capital Limited2024-10-21 | 7.33% | new |
| Morgan Stanley & Co. LLC2024-10-04 · amended | 0.00% | new |
| Morgan Stanley & Co. International plc2024-10-04 · amended | 3.33% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.